Our Services
Medical Information
Helpful Resources
Published on: 3/9/2026
Persistent symptoms after treatment for Mycoplasma genitalium are common and often driven by antibiotic resistance, an outdated regimen, reinfection, or lingering inflammation, and other conditions can cause similar discomfort; there are several factors to consider, so see below for details that may change your next steps.
Recommended next steps include prompt follow up with a clinician, a test of cure at least 3 weeks after finishing antibiotics, resistance guided therapy that typically uses doxycycline first then azithromycin if susceptible or moxifloxacin if resistant, ensuring partners are treated, avoiding sex until cleared, and seeking urgent care for severe pain, fever, or pelvic or testicular swelling.
If you've been treated for mycoplasma genitalium but still have symptoms, you're not alone. This sexually transmitted infection (STI) is known for being stubborn. Many people expect symptoms to disappear quickly after antibiotics, but with mycoplasma genitalium, recovery can be slower and sometimes requires additional treatment.
Let's walk through why symptoms may persist and what medically approved next steps look like.
Mycoplasma genitalium (often shortened to Mgen) is a sexually transmitted bacterium that infects the urethra, cervix, rectum, and sometimes the throat. It is a common cause of:
Unlike chlamydia or gonorrhea, mycoplasma genitalium is harder to detect and treat. It grows slowly and has developed resistance to several common antibiotics.
Persistent symptoms after treatment for mycoplasma genitalium can happen for several reasons. Understanding these can help you and your doctor choose the right next step.
This is the most common reason.
Mycoplasma genitalium has developed resistance to:
In many regions, more than 40–50% of strains are resistant to azithromycin. If your infection was resistant, the antibiotic may not have fully cleared the bacteria.
Older treatment strategies often used a single large dose of azithromycin. We now know that this approach can:
Current medical guidelines recommend resistance-guided therapy when available. This often involves:
If you received older treatment, your symptoms may persist because the bacteria weren't fully eradicated.
It's possible to be reinfected if:
Reinfection can feel like treatment failure but is technically a new infection.
Even after the bacteria are gone, inflammation can linger.
Your body's immune response may take time to settle, leading to:
This can last weeks, even after successful treatment.
Sometimes, symptoms aren't caused solely by mycoplasma genitalium. Other possibilities include:
If symptoms don't resolve, your doctor may evaluate for other causes.
In men and people with a penis:
In women and people with a cervix:
If you're experiencing these symptoms and want to understand whether urethritis might be causing your discomfort, a free AI-powered symptom checker can help you identify possible causes before your doctor visit.
If you're still hurting after treatment for mycoplasma genitalium, here's what evidence-based guidelines recommend.
Persistent genital symptoms should not be ignored. A clinician can:
If you have severe pelvic pain, fever, testicular swelling, or signs of pelvic inflammatory disease, seek urgent medical care.
A test of cure is often recommended:
Repeat testing helps determine whether:
In some areas, labs can test for macrolide resistance mutations.
If available, resistance testing helps guide:
Resistance-guided therapy improves cure rates and reduces unnecessary antibiotic use.
To prevent reinfection:
Partner management is essential in stopping the cycle of infection.
According to current expert guidelines, treatment often includes:
Step 1:
Step 2 (based on resistance status):
Do not self-treat or reuse leftover antibiotics. Incomplete or improper treatment increases resistance risk.
If symptoms persist, your doctor may assess for:
These complications are uncommon but important to rule out if symptoms are significant or worsening.
After effective treatment:
If symptoms are:
Healing is not always immediate, but symptoms should trend in the right direction.
Untreated mycoplasma genitalium can increase the risk of:
However, with proper diagnosis and appropriate antibiotics, serious long-term complications are uncommon.
The key is timely treatment and follow-up.
While working with your doctor:
Do not double up on antibiotics without medical advice.
Get immediate medical attention if you experience:
These symptoms may signal something more serious that needs prompt treatment.
Mycoplasma genitalium is a real and increasingly recognized cause of persistent genital symptoms. If you're still hurting after treatment, it doesn't mean you did something wrong. This bacterium is known for antibiotic resistance and treatment challenges.
The most important next steps are:
To better prepare for your medical appointment and understand if your ongoing symptoms could be related to urethritis, consider using a free AI-powered symptom assessment tool that can help you organize your concerns and questions.
Above all, don't ignore ongoing symptoms. While many cases resolve with the right antibiotics, persistent or worsening symptoms should always be discussed with a qualified healthcare professional. Early, appropriate treatment protects your long-term health.
If anything feels severe, unusual, or potentially serious, speak to a doctor right away.
(References)
* Jensen JS, Cusini M, Gomberg M, Moi H, Wilson J, Unemo M. European guideline for the management of Mycoplasma genitalium infections. Int J STD AIDS. 2022 Oct;33(11):922-933. doi: 10.1177/09564624221111032. Epub 2022 Aug 4. PMID: 35929654.
* Moi H, Reinton N, Bjørknes R. Mycoplasma genitalium: An Update on Resistance and Treatment. J Clin Microbiol. 2021 May 19;59(6):e00045-21. doi: 10.1128/JCM.00045-21. Epub 2021 May 19. PMID: 33737380; PMCID: PMC8133989.
* Sáez-Bueno J, Clavijo-Frutos E, Montaño-Mata N, Pardo-Ruiz J, García-Martín R. Mycoplasma genitalium: current issues in diagnosis and management. Future Microbiol. 2021 Feb;16:119-129. doi: 10.2217/fmb-2020-0255. Epub 2020 Nov 3. PMID: 33140510.
* Cazanicchi L, Fanti D, Zecchi M, Miramare E, Accogli M, De Tommaso L, Viale P, Mazzetti M. Emergence and Spread of Macrolide and Fluoroquinolone Resistance in Mycoplasma genitalium: An Update on Mechanisms, Prevalence, and Clinical Implications. J Clin Microbiol. 2023 Feb 22;61(2):e0013922. doi: 10.1128/jcm.00139-22. Epub 2022 Nov 22. PMID: 36416175; PMCID: PMC9948013.
* Larsen J, Jørgensen JCS, Schou E, Stensballe LG, Andersen TE, Frimodt-Møller N. Global prevalence and determinants of Mycoplasma genitalium resistance to macrolides and fluoroquinolones: A systematic review and meta-analysis. Lancet Microbe. 2023 Apr;4(4):e267-e278. doi: 10.1016/S2666-5247(23)00007-4. Epub 2023 Feb 15. PMID: 36796245.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.